Tag Archives: SARS-CoV-2

Myalgia is Regarded as ‘Top’ Symptom for COVID-19 and is Now Widely Reported

Since the onset of the 2019 Novel Coronavirus Or 2019-nCoV, so many new variants of the coronavirus disease have emerged […]

January 18, 2023

3.7M Treatment Courses of PAXLOVID are Planned for Delivery by Early 2023 to Help Combat COVID-19

According to Pfizer, they have reached an agreement with the U.S. Government for the purchase of an additional 3.7 Million […]

January 15, 2023